Anren Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anren Zhang has a total of 161 co-authors. Here are the top co-authors by number of shared publications:
Dunbing Huang
Department of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
9 shared publicationsJunyu Wang
Department of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, Tongji University School of Medicine, Shanghai, China
9 shared publications- Xiaohua Ke
Department of Rehabilitation Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
9 shared publications - Rizhao Pang
Department of Rehabilitation Medicine, General Hospital of Western Theater Command, Chengdu, China
7 shared publications Wenchun Wang
Department of Rehabilitation Medicine, General Hospital of Western Theater Command, Chengdu, China
7 shared publicationsJing Feng
Department of Rehabilitation Medicine, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China
6 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1963734
A clinical and biomarker model for predicting post-stroke cognitive impairment: a prospective cohort study
Background and objectives: Post-stroke cognitive impairment (PSCI) is highly prevalent and substantially compromises functional recovery and quality of life; however, early identification remains challenging. This study aimed to develop and validate an early prediction model for PSCI by integrating routinely available blood biomarkers with clinical characteristics. Methods: Patients with acute ischemic stroke were prospectively enrolled at Shanghai Fourth People's Hospital between March and November 2024. Cognitive function was assessed 3 months after stroke using the Telephone Montreal Cognitive Assessment (T-MoCA), a telephone-based cognitive screening instrument, with PSCI defined as a corrected T-MoCA score <19. Univariable logistic regression, Spearman correlation analysis, and variance inflation factor analysis were performed to characterize associations and predictor redundancy. Bootstrap least absolute shrinkage and selection operator (LASSO) logistic regression with 1,000 resampling iterations was used to assess variable-selection stability, followed by multivariable logistic regression and nomogram construction. Model performance was evaluated using receiver operating characteristic (ROC) analysis, calibration analysis, decision curve analysis (DCA), and clinical impact curves (CIC), with 1,000 bootstrap iterations used for internal validation. Results: A total of 198 patients were included, of whom 138 developed PSCI and 60 were classified as post-stroke cognitively normal (PSCN, non-PSCI group). The final prediction model incorporated age, prior stroke history, diabetes mellitus, small dense low-density lipoprotein (sdLDL), apolipoprotein A-I (ApoA-I), homocysteine, cystatin C, and D-dimer. The model achieved an apparent AUC of 0.798. Following 1,000 bootstrap resampling iterations, the mean AUC was 0.777 (95% CI, 0.733–0.802), and the optimism-corrected AUC was 0.762. Calibration analysis suggested reasonable agreement between predicted and observed risks, while DCA and CIC analyses indicated potential utility for PSCI risk stratification. Conclusions: This study developed and internally validated a multivariable model combining clinical characteristics and circulating biomarkers to estimate PSCI risk after acute ischemic stroke. The model showed acceptable predictive performance and may support early risk stratification.
- 14 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1963734
Open AccessA clinical and biomarker model for predicting post-stroke cognitive impairment: a prospective cohort study
Background and objectives: Post-stroke cognitive impairment (PSCI) is highly prevalent and substantially compromises functional recovery and quality of life; however, early identification remains challenging. This study aimed to develop and validate an early prediction model for PSCI by integrating routinely available blood biomarkers with clinical characteristics. Methods: Patients with acute ischemic stroke were prospectively enrolled at Shanghai Fourth People's Hospital between March and November 2024. Cognitive function was assessed 3 months after stroke using the Telephone Montreal Cognitive Assessment (T-MoCA), a telephone-based cognitive screening instrument, with PSCI defined as a corrected T-MoCA score <19. Univariable logistic regression, Spearman correlation analysis, and variance inflation factor analysis were performed to characterize associations and predictor redundancy. Bootstrap least absolute shrinkage and selection operator (LASSO) logistic regression with 1,000 resampling iterations was used to assess variable-selection stability, followed by multivariable logistic regression and nomogram construction. Model performance was evaluated using receiver operating characteristic (ROC) analysis, calibration analysis, decision curve analysis (DCA), and clinical impact curves (CIC), with 1,000 bootstrap iterations used for internal validation. Results: A total of 198 patients were included, of whom 138 developed PSCI and 60 were classified as post-stroke cognitively normal (PSCN, non-PSCI group). The final prediction model incorporated age, prior stroke history, diabetes mellitus, small dense low-density lipoprotein (sdLDL), apolipoprotein A-I (ApoA-I), homocysteine, cystatin C, and D-dimer. The model achieved an apparent AUC of 0.798. Following 1,000 bootstrap resampling iterations, the mean AUC was 0.777 (95% CI, 0.733–0.802), and the optimism-corrected AUC was 0.762. Calibration analysis suggested reasonable agreement between predicted and observed risks, while DCA and CIC analyses indicated potential utility for PSCI risk stratification. Conclusions: This study developed and internally validated a multivariable model combining clinical characteristics and circulating biomarkers to estimate PSCI risk after acute ischemic stroke. The model showed acceptable predictive performance and may support early risk stratification.
- Open Access
- 26 September 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
Combined femoral nerve block and posterior knee pain-point infiltration for early passive knee training after total knee arthroplasty: a two-center sham-controlled proof-of-concept randomized trial
Background: We assessed whether a combined regional analgesic regimen administered immediately before passive knee training on postoperative day 3 was associated with active knee range of motion (ROM) 90 days after the intervention. Methods: In this two-center, parallel-group, sham-controlled superiority trial, 220 participants were randomized 1:1. The combined-regimen group received an ultrasound-guided femoral nerve block with 20 mL of 0.5% ropivacaine and posterior knee pain-point infiltration with 5 mL of 0.5% ropivacaine (25 mL; 125 mg total). The sham-control group underwent superficial subcutaneous puncture without injection or posterior infiltration. The primary outcome was active knee ROM 90 days after the postoperative-day-3 procedure. The complete-case analysis included 208 participants with available primary-outcome data (104 per group); missing values were not imputed. Results: At 90 days, the baseline-adjusted mean difference in active ROM was 9.12° (95% confidence interval [CI], 7.17 to 11.07; P < 0.001). Immediately after the procedure, adjusted between-group differences were 35.75° (95% CI, 33.80 to 37.69) for passive ROM and − 4.02 points (95% CI, -4.31 to -3.73) for movement-related pain. Length of stay was shorter by 2.15 days (95% CI, 1.55 to 2.75). Among 208 participants with complete safety follow-up, adverse events were recorded in 16/104 (15.4%) and 15/104 (14.4%) participants, respectively (risk ratio, 1.07; 95% CI, 0.56 to 2.04). One periprosthetic tibial fracture in a sham-control participant without complete follow-up was reported separately. Conclusions: In the complete-case analysis, the combined regimen was associated with greater active ROM at 90 days and with less pain and greater passive ROM during the targeted training session. Because the intervention was delivered as a bundle, the contribution of each component cannot be determined. The study was not designed to establish safety equivalence, and 12 randomized participants lacked primary-outcome data. Trial registration: Chinese Clinical Trial Registry, ChiCTR2500099543. Registered on March 25, 2025, before patient enrollment.
- 26 September 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
Open AccessCombined femoral nerve block and posterior knee pain-point infiltration for early passive knee training after total knee arthroplasty: a two-center sham-controlled proof-of-concept randomized trial
Background: We assessed whether a combined regional analgesic regimen administered immediately before passive knee training on postoperative day 3 was associated with active knee range of motion (ROM) 90 days after the intervention. Methods: In this two-center, parallel-group, sham-controlled superiority trial, 220 participants were randomized 1:1. The combined-regimen group received an ultrasound-guided femoral nerve block with 20 mL of 0.5% ropivacaine and posterior knee pain-point infiltration with 5 mL of 0.5% ropivacaine (25 mL; 125 mg total). The sham-control group underwent superficial subcutaneous puncture without injection or posterior infiltration. The primary outcome was active knee ROM 90 days after the postoperative-day-3 procedure. The complete-case analysis included 208 participants with available primary-outcome data (104 per group); missing values were not imputed. Results: At 90 days, the baseline-adjusted mean difference in active ROM was 9.12° (95% confidence interval [CI], 7.17 to 11.07; P < 0.001). Immediately after the procedure, adjusted between-group differences were 35.75° (95% CI, 33.80 to 37.69) for passive ROM and − 4.02 points (95% CI, -4.31 to -3.73) for movement-related pain. Length of stay was shorter by 2.15 days (95% CI, 1.55 to 2.75). Among 208 participants with complete safety follow-up, adverse events were recorded in 16/104 (15.4%) and 15/104 (14.4%) participants, respectively (risk ratio, 1.07; 95% CI, 0.56 to 2.04). One periprosthetic tibial fracture in a sham-control participant without complete follow-up was reported separately. Conclusions: In the complete-case analysis, the combined regimen was associated with greater active ROM at 90 days and with less pain and greater passive ROM during the targeted training session. Because the intervention was delivered as a bundle, the contribution of each component cannot be determined. The study was not designed to establish safety equivalence, and 12 randomized participants lacked primary-outcome data. Trial registration: Chinese Clinical Trial Registry, ChiCTR2500099543. Registered on March 25, 2025, before patient enrollment.
- Open Access
- 23 September 2026
- Published by Frontiers Media SA in Frontiers in Sports and Active Living
- Vol. 8, 1919698
Schroth exercises added to bracing for adolescent idiopathic scoliosis: a systematic review and meta-analysis
Background: Bracing is the principal non-operative treatment for skeletally immature adolescents with idiopathic scoliosis. Schroth exercises are often adjunctively prescribed; however, their incremental value over bracing alone remains uncertain. Objective: To evaluate the effectiveness, safety, adherence, and treatment burden of Schroth or explicitly Schroth-based exercises added to bracing compared with bracing alone. Methods: This PROSPERO-registered systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 principles. Comparative studies of braced adolescents with idiopathic scoliosis were included. The risk of bias was assessed using version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2) or risk of bias in non-randomized studies of interventions (ROBINS-I), and certainty was assessed using Grading of Recommendation Assessment, Development and Evaluation (GRADE). Primary continuous synthesis used postintervention/final values within prespecified clinically comparable follow-up and brace-dose contexts; change score, imputed standard deviation, mixed follow-up, abstract-limited, unequal brace dose, and non-randomized analyses were treated as sensitivity and exploratory evidence. Results: Fourteen studies were included, comprising nine randomized and five non-randomized comparative studies. Randomized progression evidence was sparse and inconclusive [risk ratio: 0.44, 95% confidence interval (CI): 0.07–2.82; 71 participants]. Primary endpoint/final-value continuous analyses favored combined treatment for the Cobb angle [mean difference (MD): 3.78°, 95% CI: 2.27–5.29; 330 participants] and angle of trunk rotation (MD: 1.82°, 95% CI: 0.16–3.48; 220 participants), but heterogeneity was substantial and certainty was very low. Harm, adherence, and burden were reported incompletely. Conclusions: Schroth or Schroth-based exercises added to bracing may improve the short-term Cobb angle, while trunk-rotation effects are directionally favorable but uncertain. The evidence was insufficient to determine additional effects on the quality of life, pain, respiratory function, posture, chest-wall or rib-cage mobility, pelvic alignment, balance, gait, long-term progression, surgery, adherence, harm, or treatment burden. Schroth exercises should be framed as adjuncts to prescribed bracing, not as replacements for adequate brace wear or reasons to reduce the brace dose. Future trials should evaluate radiographic, postural, respiratory, functional, adherence, safety, burden, and participation outcomes. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261397961 , PROSPERO CRD420261397961.
- 23 September 2026
- Published by Frontiers Media SA in Frontiers in Sports and Active Living
- Vol. 8, 1919698
Open AccessSchroth exercises added to bracing for adolescent idiopathic scoliosis: a systematic review and meta-analysis
Background: Bracing is the principal non-operative treatment for skeletally immature adolescents with idiopathic scoliosis. Schroth exercises are often adjunctively prescribed; however, their incremental value over bracing alone remains uncertain. Objective: To evaluate the effectiveness, safety, adherence, and treatment burden of Schroth or explicitly Schroth-based exercises added to bracing compared with bracing alone. Methods: This PROSPERO-registered systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 principles. Comparative studies of braced adolescents with idiopathic scoliosis were included. The risk of bias was assessed using version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2) or risk of bias in non-randomized studies of interventions (ROBINS-I), and certainty was assessed using Grading of Recommendation Assessment, Development and Evaluation (GRADE). Primary continuous synthesis used postintervention/final values within prespecified clinically comparable follow-up and brace-dose contexts; change score, imputed standard deviation, mixed follow-up, abstract-limited, unequal brace dose, and non-randomized analyses were treated as sensitivity and exploratory evidence. Results: Fourteen studies were included, comprising nine randomized and five non-randomized comparative studies. Randomized progression evidence was sparse and inconclusive [risk ratio: 0.44, 95% confidence interval (CI): 0.07–2.82; 71 participants]. Primary endpoint/final-value continuous analyses favored combined treatment for the Cobb angle [mean difference (MD): 3.78°, 95% CI: 2.27–5.29; 330 participants] and angle of trunk rotation (MD: 1.82°, 95% CI: 0.16–3.48; 220 participants), but heterogeneity was substantial and certainty was very low. Harm, adherence, and burden were reported incompletely. Conclusions: Schroth or Schroth-based exercises added to bracing may improve the short-term Cobb angle, while trunk-rotation effects are directionally favorable but uncertain. The evidence was insufficient to determine additional effects on the quality of life, pain, respiratory function, posture, chest-wall or rib-cage mobility, pelvic alignment, balance, gait, long-term progression, surgery, adherence, harm, or treatment burden. Schroth exercises should be framed as adjuncts to prescribed bracing, not as replacements for adequate brace wear or reasons to reduce the brace dose. Future trials should evaluate radiographic, postural, respiratory, functional, adherence, safety, burden, and participation outcomes. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261397961 , PROSPERO CRD420261397961.
- Open Access
- 29 July 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1882198
Serum lipidomic alterations associated with post-stroke cognitive impairment: an exploratory prospective study
Background: Post-stroke cognitive impairment (PSCI) is a common complication of stroke that adversely affects long-term functional outcomes and quality of life among survivors. However, reliable biomarkers for early risk prediction remain limited. Dysregulation of lipid metabolism has been implicated in ischemic stroke and may contribute to PSCI development. Objective: This study investigated early serum lipidomic alterations associated with PSCI in patients with acute ischemic stroke and evaluated whether integrating lipidomic features with clinical indicators improves predictive performance. Methods: In this prospective cohort study, 123 patients with acute ischemic stroke were enrolled. Serum samples were obtained within 24 h of stroke onset, and untargeted lipidomic profiling was performed using ultra-high-performance liquid chromatography–high-resolution mass spectrometry. Cognitive function was assessed at 3 months using the Telephone Montreal Cognitive Assessment (T-MoCA). Patients were classified into PSCI and post-stroke cognitively normal (PSCN) groups. Candidate lipids were identified through univariate analysis, multivariable logistic regression, pathway enrichment analysis, and least absolute shrinkage and selection operator (LASSO) regression. Clinical, lipidomic, and combined prediction models were developed and internally validated. Results: Among the 123 patients, 62 developed PSCI and 61 remained cognitively normal. A total of 1,584 lipid annotations meeting MSI Level 2 criteria were retained for subsequent analyses. Although 87 lipids differed nominally between the PSCI and PSCN groups, none remained significant after false discovery rate correction. After adjustment for clinical confounders, 65 lipids remained nominally associated with PSCI. Pathway enrichment analysis implicated glycerophospholipid metabolism and choline-related phospholipid metabolism. LASSO regression identified LPC 22:6/0:0 as a candidate lipidomic feature. In the internal validation set, the clinical, lipidomic, and combined models yielded areas under the curve (AUCs) of 0.746, 0.623, and 0.763, respectively. The combined model demonstrated favorable discrimination and calibration, as well as potential clinical net benefit. Conclusion: These findings suggest early serum lipid metabolic alterations in patients who developed PSCI. LPC 22:6/0:0 may be associated with post-stroke cognitive outcomes, and a model integrating clinical and lipidomic features may support early PSCI risk stratification.
- 29 July 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1882198
Open AccessSerum lipidomic alterations associated with post-stroke cognitive impairment: an exploratory prospective study
Background: Post-stroke cognitive impairment (PSCI) is a common complication of stroke that adversely affects long-term functional outcomes and quality of life among survivors. However, reliable biomarkers for early risk prediction remain limited. Dysregulation of lipid metabolism has been implicated in ischemic stroke and may contribute to PSCI development. Objective: This study investigated early serum lipidomic alterations associated with PSCI in patients with acute ischemic stroke and evaluated whether integrating lipidomic features with clinical indicators improves predictive performance. Methods: In this prospective cohort study, 123 patients with acute ischemic stroke were enrolled. Serum samples were obtained within 24 h of stroke onset, and untargeted lipidomic profiling was performed using ultra-high-performance liquid chromatography–high-resolution mass spectrometry. Cognitive function was assessed at 3 months using the Telephone Montreal Cognitive Assessment (T-MoCA). Patients were classified into PSCI and post-stroke cognitively normal (PSCN) groups. Candidate lipids were identified through univariate analysis, multivariable logistic regression, pathway enrichment analysis, and least absolute shrinkage and selection operator (LASSO) regression. Clinical, lipidomic, and combined prediction models were developed and internally validated. Results: Among the 123 patients, 62 developed PSCI and 61 remained cognitively normal. A total of 1,584 lipid annotations meeting MSI Level 2 criteria were retained for subsequent analyses. Although 87 lipids differed nominally between the PSCI and PSCN groups, none remained significant after false discovery rate correction. After adjustment for clinical confounders, 65 lipids remained nominally associated with PSCI. Pathway enrichment analysis implicated glycerophospholipid metabolism and choline-related phospholipid metabolism. LASSO regression identified LPC 22:6/0:0 as a candidate lipidomic feature. In the internal validation set, the clinical, lipidomic, and combined models yielded areas under the curve (AUCs) of 0.746, 0.623, and 0.763, respectively. The combined model demonstrated favorable discrimination and calibration, as well as potential clinical net benefit. Conclusion: These findings suggest early serum lipid metabolic alterations in patients who developed PSCI. LPC 22:6/0:0 may be associated with post-stroke cognitive outcomes, and a model integrating clinical and lipidomic features may support early PSCI risk stratification.
- Open Access
- 14 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2100
Construction of a Risk Prediction Model of Swallowing Dysfunction During Recovery from Acute Ischemic Stroke
Objective: This study aimed to analyze risk factors for post-stroke dysphagia during the recovery phase of acute ischemic stroke and to construct a preliminary risk prediction model for patients who were eligible for bedside swallowing assessment. Methods: A retrospective analysis was performed for patients with ischemic stroke who were continuously admitted to Shanghai Fourth People’s Hospital. Swallowing function was assessed using the water swallowing test. Univariate and multivariate analyses were used to screen variables, and a predictive model was constructed using binary logistic regression. The model was visualized using a nomogram. Calibration curves and receiver operating characteristic curves were employed to assess the model’s accuracy and predictive value, while decision curve analysis was used to examine the model’s clinical relevance. Results: Overall, 209 ischemic stroke patients were included in the analysis. Univariate and multivariate logistic regression analyses identified higher NIHSS score and lower triglyceride level as independent factors associated with swallowing dysfunction (p-value < 0.05); the full model (NIHSS + TG) yielded AUCs of 0.685 (95% CI: 0.523–0.783) in the training set and 0.679 (95% CI: 0.606–0.700) in the test set, with corresponding sensitivities of 0.52 and 0.61, and specificities of 0.78 and 0.70, respectively. Compared with NIHSS alone (AUC 0.652, 95% CI: 0.518–0.746), the AUC improvement was not significant (DeLong p = 0.09), but the net reclassification improvement was 0.26 (95% CI: 0.02–0.49). Conclusions: This preliminary derivation model, based on NIHSS and triglyceride levels, demonstrates modest discrimination but provides incremental reclassification value over NIHSS alone for estimating the risk of PSD in cooperative patients. The model should be considered exploratory, and external validation is required before any clinical application.
- 14 July 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (14) , 2100
Open AccessConstruction of a Risk Prediction Model of Swallowing Dysfunction During Recovery from Acute Ischemic Stroke
Objective: This study aimed to analyze risk factors for post-stroke dysphagia during the recovery phase of acute ischemic stroke and to construct a preliminary risk prediction model for patients who were eligible for bedside swallowing assessment. Methods: A retrospective analysis was performed for patients with ischemic stroke who were continuously admitted to Shanghai Fourth People’s Hospital. Swallowing function was assessed using the water swallowing test. Univariate and multivariate analyses were used to screen variables, and a predictive model was constructed using binary logistic regression. The model was visualized using a nomogram. Calibration curves and receiver operating characteristic curves were employed to assess the model’s accuracy and predictive value, while decision curve analysis was used to examine the model’s clinical relevance. Results: Overall, 209 ischemic stroke patients were included in the analysis. Univariate and multivariate logistic regression analyses identified higher NIHSS score and lower triglyceride level as independent factors associated with swallowing dysfunction (p-value < 0.05); the full model (NIHSS + TG) yielded AUCs of 0.685 (95% CI: 0.523–0.783) in the training set and 0.679 (95% CI: 0.606–0.700) in the test set, with corresponding sensitivities of 0.52 and 0.61, and specificities of 0.78 and 0.70, respectively. Compared with NIHSS alone (AUC 0.652, 95% CI: 0.518–0.746), the AUC improvement was not significant (DeLong p = 0.09), but the net reclassification improvement was 0.26 (95% CI: 0.02–0.49). Conclusions: This preliminary derivation model, based on NIHSS and triglyceride levels, demonstrates modest discrimination but provides incremental reclassification value over NIHSS alone for estimating the risk of PSD in cooperative patients. The model should be considered exploratory, and external validation is required before any clinical application.
- 26 March 2026
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 36 (8) , 104710
Causal effects of oxidative stress on hypertension: insights integrating multi-omics and colocalization analyses
- 26 March 2026
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 36 (8) , 104710
Causal effects of oxidative stress on hypertension: insights integrating multi-omics and colocalization analyses
- Top Cited PapersOpen Access
- 21 January 2026
- Published by Elsevier in Neurobiology of Disease
- Vol. 220, 107283
New perspective on neurodegenerative diseases: Focusing on the interaction between autophagy and oxidative stress and targeted strategies
- 21 January 2026
- Published by Elsevier in Neurobiology of Disease
- Vol. 220, 107283
Top Cited PapersOpen AccessNew perspective on neurodegenerative diseases: Focusing on the interaction between autophagy and oxidative stress and targeted strategies
- 31 December 2025
- Published by Elsevier in Experimental Neurology
- Vol. 398, 115631
Therapeutic application of fecal microbiota transplantation for neurological diseases: Exploring novel mechanisms and perspectives
- 31 December 2025
- Published by Elsevier in Experimental Neurology
- Vol. 398, 115631
Therapeutic application of fecal microbiota transplantation for neurological diseases: Exploring novel mechanisms and perspectives
- Top Cited PapersOpen Access
- 31 July 2025
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 46 (8) , 752-770
Piezo1: structural pharmacology and mechanotransduction mechanisms
- 31 July 2025
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 46 (8) , 752-770
Top Cited PapersOpen AccessPiezo1: structural pharmacology and mechanotransduction mechanisms
- Open Access
- 23 July 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (177) , 240241
Exercise and pulmonary embolism: a systematic review of exercise safety, feasibility and effectiveness
Background: Long-term survivors of pulmonary embolism (PE) exhibit decreased exercise capacity, dyspnoea and a diminished quality of life. Exercise may represent a beneficial strategy for ameliorating persistent symptoms following PE. Research question: Is exercise training beneficial for improving exercise capacity and quality of life in patients with PE? Additionally, is it safe and feasible? Study design and methods: The aim of this systematic review was to evaluate the safety, feasibility and efficacy of exercise training in improving exercise capacity and quality of life in patients with PE. In order to comprehensively assess the available evidence, we conducted a systematic review using a combination of free-text terms and medical subject headings according to database requirements in PubMed, Medline, Web of Science, Scopus, Embase and the Cochrane Library from inception until 17 September 2024. Results: We included a total of nine trials including 583 patients, including 391 in the interventional group and 190 in the control group. The difference in the average adverse event rates between the exercise group (0.5%) and the control group (0%) was not significant. The overall recruitment rate was approximately 51% (range: 38–65%), the withdrawal rate was approximately 5% (range: 0–13%) and the adherence rate was 87% (range: 61–100%). The studies reported average improvements in peak oxygen consumption (exercise group: 7.55 mL·kg−1·min−1; control group: 1.95 mL·kg−1·min−1), incremental shuttle walk test distance (exercise group: 142 m; control group: 69.5 m), vitality scores (exercise group: 13.95; control group: 3.95), and role emotional scores (exercise group: 12.05; control group: −0.1). However, due to considerable discrepancies in the scoring systems, an average improvement in Pulmonary Embolism Quality of Life questionnaire score could not be determined. Notably, no improvement in dyspnoea was reported. Conclusion: This systematic review indicates that exercise training seems to be safe and feasible for patients with PE. It appears to enhance patients' exercise capacity and quality of life, although its impact on alleviating dyspnoea remains limited. However, given the absence of large-scale randomised controlled trials, these findings should be interpreted with caution.
- 23 July 2025
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 34 (177) , 240241
Open AccessExercise and pulmonary embolism: a systematic review of exercise safety, feasibility and effectiveness
Background: Long-term survivors of pulmonary embolism (PE) exhibit decreased exercise capacity, dyspnoea and a diminished quality of life. Exercise may represent a beneficial strategy for ameliorating persistent symptoms following PE. Research question: Is exercise training beneficial for improving exercise capacity and quality of life in patients with PE? Additionally, is it safe and feasible? Study design and methods: The aim of this systematic review was to evaluate the safety, feasibility and efficacy of exercise training in improving exercise capacity and quality of life in patients with PE. In order to comprehensively assess the available evidence, we conducted a systematic review using a combination of free-text terms and medical subject headings according to database requirements in PubMed, Medline, Web of Science, Scopus, Embase and the Cochrane Library from inception until 17 September 2024. Results: We included a total of nine trials including 583 patients, including 391 in the interventional group and 190 in the control group. The difference in the average adverse event rates between the exercise group (0.5%) and the control group (0%) was not significant. The overall recruitment rate was approximately 51% (range: 38–65%), the withdrawal rate was approximately 5% (range: 0–13%) and the adherence rate was 87% (range: 61–100%). The studies reported average improvements in peak oxygen consumption (exercise group: 7.55 mL·kg−1·min−1; control group: 1.95 mL·kg−1·min−1), incremental shuttle walk test distance (exercise group: 142 m; control group: 69.5 m), vitality scores (exercise group: 13.95; control group: 3.95), and role emotional scores (exercise group: 12.05; control group: −0.1). However, due to considerable discrepancies in the scoring systems, an average improvement in Pulmonary Embolism Quality of Life questionnaire score could not be determined. Notably, no improvement in dyspnoea was reported. Conclusion: This systematic review indicates that exercise training seems to be safe and feasible for patients with PE. It appears to enhance patients' exercise capacity and quality of life, although its impact on alleviating dyspnoea remains limited. However, given the absence of large-scale randomised controlled trials, these findings should be interpreted with caution.